IP Library Granted Patent US 7,312,301
Granted Patent B2
US 7,312,301 · App. 10/751,010 · Granted Dec 25, 2007

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,312,301
App. No.
10/751,010
Granted
Dec 25, 2007
Kind
B2
Abstract

The present invention provides both crosslinked polymer compositions capable of forming hydrogel upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogel, are also provided.

Claims (20)

1. A method for making a crosslinked polymer composition capable of forming a hydrogel comprising:

providing a first composition comprising at least one thiosulfonate polymer derivative, wherein said at least one thiosulfonate polymer derivative has the formula,

wherein POLY is a water-soluble polymer, (n) is 3 to about 25, X is a linking group, Y is a moiety derived from a molecule having at least three nucleophilic groups, and R is hydrogen, or an organic radical;

exposing said first composition to a base under conditions sufficient to initiate crosslinking between said thiosulfonate functional groups; and

allowing said crosslinking to proceed to thereby form said crosslinked polymer composition capable of forming a hydrogel.

2. The method of claim 1 , wherein said first composition is substantially free of a crosslinking agent or redox catalyst.

3. The method of claim 1 , wherein said at least one thiosulfonate polymer derivative is a 3 to about 100 arm thiosulfonate ester of a water-soluble polymer.

4. The method of claim 1 , wherein said first composition comprises a single thiosulfonate polymer derivative component capable of crosslinking upon exposure to a base.

5. The method of claim 1 , wherein POLY is a poly(ethyene glycol); (n) is 4; X is selected from the group consisting of alkylene groups, alkylene amides, alkylene esters, and alkylene ethers; and Y is derived from a moiety selected from the group consisting of glycerol, oligoglycerols, pentaerythritol, carbohydrates, cyclodextrin, and amine analogues thereof.

6. The method of claim 1 , wherein said first composition further comprises at least one active agent.

7. The method of claim 6 , further comprising incorporating at least one biologically active moiety in the hydrogel.

8. The method of claim 6 , wherein said at least one biologically active moiety is entrapped within the crosslinked polymer composition during said crosslinking or is covalently linked to said at least one thiosulfonate polymer derivative.

9. A method for forming a crosslinked polymer composition capable of forming a hydrogel having desired physical properties from a single component hydrogel-forming composition, said method comprising:

providing a single component hydrogel-forming composition comprising a thiosulfonate polymer derivative, wherein said thiosulfonate polymer derivative has the formula,

wherein POLY is a water-soluble polymer, (n) is 3 to about 25, X is a linking group, Y is a moiety derived from a molecule having at least three nucleophilic groups, and R is hydrogen, or an organic radical;

exposing said single component hydrogel forming composition to a base under conditions sufficient to initiate crosslinking between said thiosulfonate functional groups; and

allowing said crosslinking to proceed and thereby form said crosslinked polymer composition capable of forming a hydrogel.

10. The method of claim 9 , wherein said base has a pH ranging from about 7.4 to about 9.0.

11. The method of claim 9 , wherein said single component hydrogel-forming composition is exposed to said base at a temperature ranging from about 20° C. to about 50° C.

12. The method of claim 9 , wherein said thiosulfonate polymer derivative is present in said single component hydrogel-forming composition at a concentration ranging from about 2% w/v to about 25% w/v.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2004
From: FANG, ZHIHAO; BENTLEY, MICHAEL D.
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 014775/0687 →